Latest in: Events
The Leyden Labs team participated in HERA's recent Implementation Dialogue on July 3 in Brussels. In this dialogue, Commissioner Hadja Lahbib actively listened to a set of diverse stakeholders, who can each help prepare …
The Symposium on the Pandemic Threat of Influenza and Other Respiratory Viruses was held on September 15, 2025 in Singapore, hosted by Duke-NUS Medical School. Leyden Labs was honored to support this event, which …
Earlier this week, Jaap Goudsmit, Chief Scientist of Leyden Labs, gave a talk on monoclonal antibodies as preventive tools for H5N1 outbreaks, at the global consultation of the World Health Organization (WHO).
Leyden Labs CEO Koenraad Wiedhaup will deliver a corporate presentation at the 42nd Annual J.P. Morgan Healthcare Conference, taking place January 8-11, 2024 in San Francisco, CA.
We’re pleased to share that Leyden Labs CEO Koenraad Wiedhaup will present at the 41st Annual J.P. Morgan Healthcare Conference. Koenraad’s presentation will take place Wednesday, January 11, 2023, at 11:30 a.m. PST in …
OUR NEW APPROACH | OUR TEAM | JOIN OUR MISSION | NEWS | CAREERS
Contact
Media inquiries
Stay updated
Leyden Laboratories B.V.
Leiden Laboratory
Emmy Noetherweg 2
2333 BK Leiden
The Netherlands
Leyden Labs Asia Pte. Ltd.
79 Science Park Drive
#04-05, Cintech IV
Singapore 118264
© Leyden Labs, 2026 | Privacy Statement | Design by Ape to Zebra
